ALEX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Alexander & Baldwin Inc (ALEX) is not a good buy for a beginner investor with a long-term strategy at this time. The company's recent financial performance shows significant declines in revenue, net income, and EPS, while hedge funds are heavily selling the stock. Additionally, the company is in the process of going private at a price of $21.20 per share, limiting any potential upside. Analysts have downgraded the stock to Neutral, and there are no strong positive catalysts to suggest significant growth or returns in the near future.
The technical indicators are mixed. The MACD is below 0 and negatively contracting, suggesting bearish momentum. The RSI is neutral at 55.145, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot point of 20.806, with resistance at 20.832 and support at 20.779. However, these signals are not strong enough to justify a buy.
The gross margin increased by 9.95% YoY in the latest quarter, which is a positive sign for operational efficiency.
The company is going private at $21.20 per share, capping any significant upside potential. Hedge funds are selling heavily, with a 778.93% increase in selling activity over the last quarter. Financial performance has deteriorated significantly, with revenue down 18.36% YoY, net income down 69.64% YoY, and EPS down 70.59% YoY.
In Q4 2025, the company's revenue dropped to $50.99 million (-18.36% YoY), net income fell to $3.78 million (-69.64% YoY), and EPS declined to $0.05 (-70.59% YoY). However, gross margin improved to 45.4% (+9.95% YoY).
Analysts have downgraded the stock to Neutral from Buy/Overweight. Alliance Global set a price target of $20.85, down from $22, citing the company's going-private deal. Piper Sandler maintained a price target of $21 but downgraded the stock to Neutral, stating no competing bids are expected for the $21.20 per share buyout offer.
